Study number 8539-627
Screening Appointments Available!
Dates
Oct 30 2024-Nov 12 2024
Location
Daytona Beach, Florida
Age
18-65
Gender
Male or Female
Compensation
$3,552
Group
Part 1 Group 3b
Study Details
This is a research study for an investigational drug being developed for the treatment of Primary Sjögren’s Syndrome, an autoimmune disorder in which the immune system mistakenly attacks healthy cells in the body.
Fortrea Daytona Beach, FL is recruiting for:
- Healthy Non-Smoking Adults, age 18-65
- Body Mass Index between 18.5-30
- Study involves 1 stay of 5 overnights & 1 follow-up visit*
- Compensation up to $3,552 may be provided for time and participation*
- Refer a friend to receive $350 per qualified referral
*Additional out-patient visits may be required at the end of the study, resulting in additional compensation of up to
$198 per additional visit.
Additional Details
Call Now to Schedule Your Screening Appointment!
Part 1 Group 3b:
Check-in: Oct 30
Check-out: Nov 4
Follow up Visit: Nov 12